Status:
COMPLETED
Relation Between Plasma Vitamin K2 and Glycemic Control and Metabolic Parameters in Type 2 Diabetic Patients.
Lead Sponsor:
Cairo University
Conditions:
Vitamin k2 in Type 2 DM
Eligibility:
All Genders
20-65 years
Brief Summary
Background and Rationale: The agents inducing type 2 diabetes are yet to be clarified. Current studies show that several genetic and environmental parameters are associated with type 2 diabetes . Vit...
Detailed Description
The frequency of diabetes mellitus is increasing globally and it is expected that this latent disorder will affect 300 million by 2025. Type 2 diabetes mellitus (T2DM) is a metabolic and chronic disea...
Eligibility Criteria
Inclusion
- Men and women aged 20 to 65 years old with controlled and uncontrolled DM .
Exclusion
- • Subjects with hepatic , gastrointestinal or cardiovascular disease
- Subjects with osteoporosis.
- Subjects using vitamin supplements containing vitamin K.
- Subjects using oral anticoagulants.
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 5 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04387019
Start Date
April 24 2020
End Date
February 5 2021
Last Update
June 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Manial, Egypt, 11521